HR Execs on the Move

Cvrx

www.cvrx.com

 
CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.cvrx.com
  • 9201 W Broadway Ave Ste 650
    Minneapolis, MN USA 55445
  • Phone: 763.416.2840

Executives

Name Title Contact Details
Robert John
 Chief Revenue Officer Profile
Jessica Berger
 Human Resources Director Profile
Tonya Austin
 Chief Human Resources Officer Profile

Similar Companies

Abacus Medical Equipment Supplies Inc

Abacus Medical Equipment Supplies Inc is a Fair Oaks, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Healthstar Laser Services Inc

Healthstar Laser Services Inc is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ONC Solutions

ONC Solutions is a Acton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroOne Incorporated

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.

OCULO PLASTIK

OCULO PLASTIK, INC is a Montrí©al, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.